This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Rsem, Limited Partnership. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Malika Oubaha: Innovator in Cellular Senescence Modulation
Introduction
Malika Oubaha is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of cellular senescence, particularly through her innovative research and patent work. Her dedication to advancing scientific knowledge has positioned her as a key figure in her area of expertise.
Latest Patents
Malika Oubaha holds a patent for "Compositions comprising SASP modulators and senescence attenuators and uses thereof for modulating cellular senescence." This patent describes compositions and methods for modulating cellular senescence in cells and inducing the senescence-associated secretory phenotype (SASP). The methods involve modulating the level or activity of IRE1a to control cellular senescence and the induction of the SASP. Additionally, the patent outlines methods for treating and preventing ocular vascular diseases by using biguanide compounds in ophthalmic compositions.
Career Highlights
Malika Oubaha is associated with Rsem, Limited Partnership, where she continues to explore innovative solutions in her field. Her work has garnered attention for its potential applications in treating various diseases related to cellular senescence.
Collaborations
Malika collaborates with notable colleagues, including Przemyslaw Sapieha and Frédérick Antoine Mallette. These partnerships enhance her research and contribute to the advancement of knowledge in cellular senescence.
Conclusion
Malika Oubaha's contributions to the field of cellular senescence modulation are noteworthy. Her innovative patent and collaborative efforts reflect her commitment to advancing scientific research and improving health outcomes.